We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
8.50 | 3.86% | 228.50 | 228.50 | 231.00 | 234.00 | 221.00 | 222.00 | 323,586 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -4.90 | 221.17M |
TIDMOXB TIDMAV.
RNS Number : 8771L
Oxford Biomedica PLC
06 October 2016
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ----------------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Oxford Biomedica plc the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- ---------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights --------------------------------------------------------------------- ------------------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------- ------------------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------- ------------------------------------------ An event changing the breakdown of voting rights --------------------------------------------------------------------- ------------------------------------------ Other (please specify): ----------------------------------------------------------- -------- ------------------------------------------ 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- -------------------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) BNY Norwich Union Nominees Limited 15,725,017* Chase (GA Group) Nominees Limited 193,049,729* State Street Nominees Limited 40,238,090* *denotes direct interest Chase (GA Group) Nominees Limited 19,344,658 Chase Nominees Limited 7,709,254 Vidacos Nominees Limited 11,939,558 ------------------------------------------------------------- -------------------------------------------------- 5. Date of the transaction 04 October 2016 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- -------------------------------------------------- 6. Date on which issuer 05 October 2016 notified: ------------------------------------------------------------- -------------------------------------------------- 7. Threshold(s) that is/are >10% to <10% Change at Combined crossed or Interest Level reached: (vi, vii) AND 9% to 8% Change at Direct Interest Level (Box 8A&B) ------------------------------------------------------------- -------------------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after of to the triggering the triggering transaction shares transaction if possible using the ISIN CODE --------------- ----------------------------- -------------------------------------------------------------- Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights --------------- ------------- -------------- ------------ ---------------------------- ------------------ Direct Direct Indirect Direct Indirect (xi) (xii) --------------- ------------- -------------- ------------ -------------- ------------ ------- --------- Ordinary Shares GB00066458157 282,975,178* 282,975,178* 288,006,306 249,012,836 38,993,470 8.06% 1.26% ------------- -------------- ------------ -------------- ------------ ------- --------- * Includes Right to Recall Loaned Shares (6,335,351) -------------------------------------------------------------------------------------------------------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. --------------- ------------- -------------- ------------------------------------------ ------------------ RIGHT TO 5,791,351* RECALL LOANED SHARES N/A N/A *DIRECT INTEREST 0.19% --------------- ------------- -------------- ------------------------------------------ ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 293,797,657 9.51% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------ The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Proxy Voting: ------------------------------------------------------------------------------ 10. Name of the proxy holder: See Section 4 --------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold:
--------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------- ------------------------------- 13. Additional information: Figures are based the total number of voting rights of 3,087,953,461 as per the Company's Total Voting Rights Announcement of 4 October 2016. --------------------------------------------- ------------------------------- 14. Contact name: Tim Watts --------------------------------------------- ------------------------------- 15. Contact telephone number: 01865 783000 --------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNAWRNKARRRA
(END) Dow Jones Newswires
October 06, 2016 04:24 ET (08:24 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions